Indian drugmaker OK’d to launch generic Lipitor – Yahoo Finance

Under Watson's deal with Pfizer, Pfizer will receive an estimated 70 percent of those sales. Under complex U.S. patent law, because Ranbaxy was the first company to successfully challenge Pfizer's Lipitor patent, it has the sole right to compete ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>